false
zh-CN,zh-TW,en,fr,de,ja,ko,pt,es,th,vi
Catalog
2023 ACMG Annual Clinical Genetics Meeting Digital ...
Impact of processed pseudogene insertions in genet ...
Impact of processed pseudogene insertions in genetic testing as cause of monogenic diseases: insertion in
CLCN1
gene causing Myotonia Congenita
Back to course
Pdf Summary
This study discusses the impact of processed pseudogene insertions in genetic testing as a cause of monogenic diseases, specifically focusing on a case of autosomal recessive myotonia congenita. Myotonia congenita is a rare muscle disorder characterized by muscle stiffness and the inability of muscles to relax after contraction. It is caused by mutations in the CLCN1 gene.<br /><br />The study reports on a 3-year-old female patient who presented with myotonia at 14 months of age. Genomic sequencing was performed to identify the causative variant, but no good candidate was initially found. Structural variants were then considered, and a deep intronic homozygous insertion of approximately 750bp was identified in intron 14 of the CLCN1 gene.<br /><br />Further investigation showed that the inserted region mapped exclusively to the coding region and UTR of the UQCRH gene, which is unrelated to myotonia congenita. It was suspected that this insertion was the result of a retrotransposition event. However, because CLCN1 is not expressed in the available sample (peripheral blood), RNA-sequencing was not feasible. CLCN1 is primarily expressed in skeletal muscle and testis.<br /><br />The study concludes that this case is the third reported instance of a processed pseudogene insertion causing a monogenic disorder. The analysis of structural variants in genomic sequencing is challenging and time-consuming but can effectively screen for processed pseudogene insertions. The study highlights the importance of genomic sequencing as a first-tier approach for the diagnosis of rare disorders.<br /><br />Overall, this study provides valuable insights into the impact of processed pseudogene insertions in genetic testing and emphasizes the role of genomic sequencing in diagnosing rare disorders.
Asset Subtitle
Co-Author - Kornelia Tripolszki, PhD; Co-Author - Javier Martini, MD; Co-Author - Kapil Kampe, PhD; Co-Author - Vasiliki Karageorgou, MSc; Co-Author - Mohamed Almuhaizea, MD; Co-Author - Catarina Pereira, MSc; Co-Author - Stephanie Weissgraeber, PhD; Co-Author - Omid Paknia, PhD; Presenting Author - Jorge Pinto-Basto, MD; Co-Author - Peter B. Bauer, MD;
Meta Tag
Genetic Testing
Genome sequencing
Genomic Methodologies
Musculoskeletal system
NextGen Sequencing
Sequencing
Variant Detection
Co-Author
Kornelia Tripolszki, PhD
Co-Author
Javier Martini, MD
Co-Author
Kapil Kampe, PhD
Co-Author
Vasiliki Karageorgou, MSc
Co-Author
Mohamed Almuhaizea, MD
Co-Author
Catarina Pereira, MSc
Co-Author
Stephanie Weissgraeber, PhD
Co-Author
Omid Paknia, PhD
Co-Author
Peter B. Bauer, MD
Presenting Author
Jorge Pinto-Basto, MD
Keywords
processed pseudogene insertions
genetic testing
monogenic diseases
autosomal recessive myotonia congenita
CLCN1 gene
muscle disorder
genomic sequencing
structural variants
retrotransposition event
rare disorders
© 2025 American College of Medical Genetics and Genomics. All rights reserved.
×